R. Gelman

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

E. Winer, A. Sorensen, R. Gelman, 2020, Breast Cancer Research.

Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy.

E. Winer, R. Gelman, J. Garber, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.

G. Sledge, R. Gelman, C. Osborne, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial

G. Sonpavde, E. Heath, H. Rana, 2023, JCO oncology practice.

Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).

E. Winer, A. Sorensen, R. Gelman, 2013 .